YU47648B - Sredstvo za suspendovanje, konzerviranje i skladištenje ćelija, u prvom redu eritrocita i njegova primena - Google Patents

Sredstvo za suspendovanje, konzerviranje i skladištenje ćelija, u prvom redu eritrocita i njegova primena

Info

Publication number
YU47648B
YU47648B YU222890A YU222890A YU47648B YU 47648 B YU47648 B YU 47648B YU 222890 A YU222890 A YU 222890A YU 222890 A YU222890 A YU 222890A YU 47648 B YU47648 B YU 47648B
Authority
YU
Yugoslavia
Prior art keywords
application
eritrocites
preservation
suspension
cells
Prior art date
Application number
YU222890A
Other languages
English (en)
Other versions
YU222890A (sh
Inventor
K. Fickenscher
Original Assignee
Behringwerke Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag. filed Critical Behringwerke Ag.
Publication of YU222890A publication Critical patent/YU222890A/sh
Priority to HRP-2228/90A priority Critical patent/HRP940754A2/hr
Publication of YU47648B publication Critical patent/YU47648B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Dentistry (AREA)
  • Pathology (AREA)
  • Environmental Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

u prvom redu eritrocita, naznačeno t ime, što sadrži u vodenom, puferovanom rastvoru, supstancu koja se viševalentnim jonovima metala gradi helate.- Prijava sadrži još 5 zavisnih zahteva.
YU222890A 1989-11-24 1990-11-22 Sredstvo za suspendovanje, konzerviranje i skladištenje ćelija, u prvom redu eritrocita i njegova primena YU47648B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-2228/90A HRP940754A2 (en) 1989-11-24 1994-10-25 Medium for the storage and suspension of cells, particularly erythrocites

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3938907A DE3938907C2 (de) 1989-11-24 1989-11-24 Mittel zum Lagern und Suspendieren von Zellen, insbesondere Erythrozyten

Publications (2)

Publication Number Publication Date
YU222890A YU222890A (sh) 1993-05-28
YU47648B true YU47648B (sh) 1995-12-04

Family

ID=6394106

Family Applications (1)

Application Number Title Priority Date Filing Date
YU222890A YU47648B (sh) 1989-11-24 1990-11-22 Sredstvo za suspendovanje, konzerviranje i skladištenje ćelija, u prvom redu eritrocita i njegova primena

Country Status (8)

Country Link
US (1) US5554527A (sh)
EP (1) EP0431385A1 (sh)
JP (1) JP3003945B2 (sh)
AU (1) AU648999B2 (sh)
CA (1) CA2030757C (sh)
DE (1) DE3938907C2 (sh)
PT (1) PT95980B (sh)
YU (1) YU47648B (sh)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256571A (en) * 1991-05-01 1993-10-26 Cytyc Corporation Cell preservative solution
JP2603576B2 (ja) * 1992-03-05 1997-04-23 株式会社いかがく 尿中の細胞保存方法
FR2726574B1 (fr) * 1994-11-04 1997-01-17 Univ Paris Curie Procede de dissociation des cellules eucaryotes en culture
DE19728161C2 (de) * 1997-07-02 2000-06-29 Guenter Kamp Verdünner und Verfahren zur Konservierung von Ebersperma
DE19735460A1 (de) 1997-08-16 1999-02-18 Rolf Prof Dr Med Zander Spül- oder Lagerungsflüssigkeit für Blutzellen
US5972592A (en) * 1997-12-29 1999-10-26 Cornell Research Foundation, Inc. Increasing reproductive efficiency of bull semen using fucose or a compound with a fucose moiety
US6045990A (en) * 1998-07-09 2000-04-04 Baust; John M. Inclusion of apoptotic regulators in solutions for cell storage at low temperature
CA2305198A1 (en) * 1998-08-03 2000-02-17 Toh-Men Co., Ltd. Solution for resuscitating multicellular organism cells and method for resuscitating multicellular organism cells by using the same
US6413713B1 (en) 1998-10-30 2002-07-02 Hyperbaric Systems Method for preserving blood platelets
US20070048726A1 (en) * 2000-01-14 2007-03-01 Biolife Solutions, Inc. Methods and Compositions for the Control of Molecular-Based Cell Death During Preservation of Cells, Tissues or Organs in a Gel-Like State
WO2003000052A1 (en) * 2001-06-26 2003-01-03 Human Biosystems Preservation of blood platelets at cold temperatures
US7309468B2 (en) 2002-05-13 2007-12-18 Becton, Dickinson And Company Protease inhibitor sample collection system
US7074561B2 (en) * 2002-10-22 2006-07-11 Biomerieux, Inc. Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA
CA2522941A1 (en) * 2003-04-23 2004-11-04 Human Biosystems Improved methods and solutions for storing donor organs
WO2006050479A2 (en) 2004-11-01 2006-05-11 George Mason University Compositions and methods for diagnosing colon disorders
WO2008079972A2 (en) 2006-12-20 2008-07-03 Bayer Healthcare Llc 4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
AU2008282780B2 (en) * 2007-08-01 2014-04-17 Dana- Farber Cancer Institute Enrichment of a target sequence
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
EP2490751B1 (en) 2009-10-23 2016-11-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
US8623603B2 (en) 2010-03-08 2014-01-07 Dana-Farber Cancer Institute, Inc. Full cold-PCR enrichment with reference blocking sequence
CN103079567A (zh) 2010-04-17 2013-05-01 拜尔健康护理有限责任公司 用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物
EP3333269B1 (en) 2011-03-31 2021-05-05 Dana-Farber Cancer Institute, Inc. Methods to enable multiplex cold-pcr
US9402866B2 (en) 2011-04-07 2016-08-02 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
US8748097B1 (en) 2011-12-02 2014-06-10 President And Fellows Of Harvard College Identification of agents for treating calcium disorders and uses thereof
EP2827882B1 (en) 2012-02-21 2020-04-08 Cytonics Corporation Systems, compositions, and methods for transplantation
US9133490B2 (en) 2012-05-16 2015-09-15 Transgenomic, Inc. Step-up method for COLD-PCR enrichment
WO2015031654A2 (en) 2013-08-28 2015-03-05 Cytonics Corporation Systems, compositions, and methods for transplantation and treating conditions
SG10202012249YA (en) 2014-12-08 2021-01-28 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
EP3289074B1 (en) 2015-04-28 2023-10-04 Université de Strasbourg Clinical gene signature-based human cell culture model and uses thereof
WO2017214068A1 (en) 2016-06-05 2017-12-14 Berg Llc Systems and methods for patient stratification and identification of potential biomarkers
CA2932910A1 (en) 2016-06-14 2017-12-14 Entos Pharmaceuticals Inc. Methods for diagnosing and treating metastatic cancer
CN106561634A (zh) * 2016-11-14 2017-04-19 北京乐普医疗科技有限责任公司 一种红细胞保存液及其制备方法
WO2018111835A1 (en) 2016-12-12 2018-06-21 Dana-Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of dna molecules prior to mutation enrichment and/or mutation detection
CN106993606A (zh) * 2017-04-20 2017-08-01 苏州新赛美生物科技有限公司 一种不含蛋白和血清的细胞冻存液及其制备方法
WO2019023243A1 (en) 2017-07-24 2019-01-31 Dana-Farber Cancer Institute, Inc. METHODS AND COMPOSITIONS FOR SELECTING AND AMPLIFYING DNA TARGETS IN A SINGLE REACTION MIXTURE
CN109307769B (zh) * 2017-07-28 2022-06-28 上海瀚联医疗技术股份有限公司 一种用于12mmol/L的血糖溶液配置方法
CN109307777B (zh) * 2017-07-28 2022-06-17 上海瀚联医疗技术股份有限公司 一种适用于葡萄糖/乳酸分析仪用的血糖校准液配置方法
CN109307770B (zh) * 2017-07-28 2022-06-17 上海瀚联医疗技术股份有限公司 一种血糖校准液配置方法
CA3138566A1 (en) 2019-04-30 2020-11-05 Larimar Therapeutics, Inc. Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
WO2022047359A1 (en) 2020-08-31 2022-03-03 Berg Llc Protein biomarkers for pancreatic cancer
WO2022172959A1 (ja) * 2021-02-09 2022-08-18 株式会社彩 細胞処理剤
IL307530A (en) 2021-04-06 2023-12-01 Bpgbio Inc Estrogen receptor-like (ER) breast cancer protein markers LUMINAL A (LA) and LUMINAL B1 (LB1)
CN118661103A (zh) 2021-04-06 2024-09-17 布普格生物制药公司 雌激素受体(er)阳性样和雌激素受体(er)阴性样乳腺癌的蛋白质标志物
CA3214833A1 (en) 2021-04-06 2022-10-13 Bpgbio, Inc. Protein markers for the prognosis of breast cancer progression
US20230357851A1 (en) 2022-04-06 2023-11-09 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring frataxin-replacement therapy
WO2023240201A1 (en) 2022-06-08 2023-12-14 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962125A (en) * 1975-01-13 1976-06-08 Coulter Diagnostics, Inc. Multi-purpose diluent for use in blood analysis by electronic instrumentation of the coulter type
US4090977A (en) * 1976-11-22 1978-05-23 Research Corporation Osmotically balanced anticoaglant
US4267269A (en) * 1980-02-05 1981-05-12 Baxter Travenol Laboratories, Inc. Red cell storage solution
JPS56139419A (en) * 1980-03-31 1981-10-30 Kuraray Co Ltd Erythrocytic preservative and erythrocytic pharmaceutical for preservation
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
US4405719A (en) * 1981-05-29 1983-09-20 Coulter Electronics, Inc. Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; diluents therefor; and combination stabilization procedures
US4489162A (en) * 1981-12-21 1984-12-18 American Hospital Supply Corporation Fresh blood (unfixed) hematology control
US4420461A (en) * 1982-05-26 1983-12-13 Ortho Diagnostic Systems Inc. Agglutination-inhibition test kit for detecting immune complexes
DE3225408A1 (de) * 1982-07-07 1984-01-12 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Waessrige loesung zum suspendieren und lagern von zellen, insbesondere erythrozyten
FR2542617B2 (fr) * 1982-07-09 1986-06-06 Rgl Transfusion Sanguine Centr Solution protectrice pour la conservation de cellules fonctionnelles
US4681839A (en) * 1982-09-23 1987-07-21 Swartz Mitchell R Systems to preserve living tissue
DE3322847A1 (de) * 1983-06-24 1985-01-03 Coulter Electronics, Inc., Hialeah, Fla. Verfahren zur stabilisierung von biologischen zellen sowie danach stabilisierte biologische zellzusammensetzungen
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
US4585735A (en) * 1984-07-19 1986-04-29 American National Red Cross Prolonged storage of red blood cells
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
US4774088A (en) * 1986-01-08 1988-09-27 The United States Of America As Represented By The Deptment Of Health And Human Services Method and additives for improving the quality and shelf life of stored blood
JPS6310732A (ja) * 1986-03-07 1988-01-18 Takeda Chem Ind Ltd 血液保存用組成物
US4961928A (en) * 1986-03-19 1990-10-09 American Red Cross Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
US4769318A (en) * 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4880786A (en) * 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
GB8708181D0 (en) * 1987-04-06 1987-05-13 Wensley R Extraction of protein from blood
DE3722984A1 (de) * 1987-07-11 1989-01-19 Biotest Pharma Gmbh Waessrige loesung zum suspendieren und lagern von zellen, insbesondere erythrozyten
US4874690A (en) * 1988-08-26 1989-10-17 Cryopharm Corporation Lyophilization of red blood cells
IT1269958B (it) * 1994-06-28 1997-04-16 Marcotex Srl Procedimento per la produzione di tessuti a spugna

Also Published As

Publication number Publication date
PT95980B (pt) 1998-04-30
YU222890A (sh) 1993-05-28
JP3003945B2 (ja) 2000-01-31
DE3938907A1 (de) 1991-05-29
DE3938907C2 (de) 1999-11-04
EP0431385A1 (de) 1991-06-12
JPH03209301A (ja) 1991-09-12
US5554527A (en) 1996-09-10
PT95980A (pt) 1991-09-13
CA2030757C (en) 2001-06-05
AU6690590A (en) 1991-05-30
CA2030757A1 (en) 1991-05-25
AU648999B2 (en) 1994-05-12

Similar Documents

Publication Publication Date Title
YU47648B (sh) Sredstvo za suspendovanje, konzerviranje i skladištenje ćelija, u prvom redu eritrocita i njegova primena
GR861300B (en) Supercritical ammonia treatment of lignocellulosic materials
NO871057L (no) Fremgangsmaate for reduksjon av permeabiliteten i en oljebaerende formasjon.
DE3876820D1 (de) Bohr- und gewindeschneidwerkzeug.
DE3584657D1 (de) Schnelles, zweistufiges, dynamisches adressumsetzungsverfahren und dessen geraete.
IT8521968A0 (it) Derivati di 1,2-benzisotiazol-3-ilpiperazina analgesici.
DE68922941D1 (de) Bedingungsschreib-RAM.
FI874292A (fi) Foerfarande foer framstaellning av borsyrasuspensioner.
FI853456L (fi) Expektorant.
DE3685812D1 (de) Mechanismus zum zurueckziehen im bohrloch.
DE69001609D1 (de) Herstellung von niedrigviskosen fotografischen kleinteilchen-dispersionen in gelatine.
EP0301181A3 (en) Reagent for reticulocyte counting by flow cytometry
NO890867D0 (no) Fluidum-proevetaker, saerlig for benyttelse i en oljebroenn.
DE3784728D1 (de) Reinigung von rekombinantem interleukin-1.
OA06778A (fr) Alliage mère d'alluminium, de titane et de bore.
KR870000031A (ko) 고려인삼 엑기스의 추출법
EP0261719A3 (en) Thermochemiluminescent cyclodextrin complexes
GB1369487A (en) Pin for a hinge
ES8900068A1 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
KR860009019A (ko) 항세균 작용 및 β- 락타마제 억제 작용을 갖는 퀴놀린- 락타민 유도체의 제조 방법
DE68921256D1 (de) Hydrodynamisches Lager.
GB2177644B (en) Electrode-tool for electroerosive drilling of holes in workpieces and methods of electroerosive drilling of holes in workpieces by such electrode-tool.
IE42348L (en) Pyridazone herbicide in the form of an aqueous suspension
EP0162355A3 (en) Motor-bearing, especially hydrodynamic bearing
KR850005777A (ko) 신포접화합물의 제조방법